10-Q quarterly report · filed Nov 3, 2026

Leidos (LDOS) Q4 2026 10-Q Quarterly Report

Short answer

Leidos (LDOS) filed its Q4 2026 10-Q quarterly report on Nov 3, 2026 for the quarter ended Oct 2, 2026. Quarterly revenue was $4.6B (up 3.8% year over year) with net income of $410M.

Q4 2026 key financials · XBRL

Revenue
$4.6B
+3.8% YoY · +1.5% QoQ
Net income
$410M
+11.7% YoY · +15.8% QoQ
Operating margin
12.0%
EPS (diluted)
$3.30
+17.0% YoY · +17.4% QoQ

Source: XBRL data from the Leidos (LDOS) Q4 2026 10-Q on SEC EDGAR. USD.

Leidos Q4 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $4.630B, up 3.6% YoY from $4.469B
  • Operating margin 11.9% vs 12.0% YoY, net income $1.104B vs $1.127B
  • Homeland best performer: revenue $1.024B, up 32.1%; Health weakest: $1.068B, down 11.7%
  • Operating cash flow decreased $188M YoY; investing outflow $48M, financing outflow $549M
  • Federal funding secured through December 11, 2026; potential shutdown risk after continuing resolution expiration

Risk Factors

  • No material changes to previously disclosed risk factors since the January 2, 2026 Form 10-K
  • Carried-forward risks remain Leidos’s principal disclosed risk exposures across regulatory, operational, market, and financial categories

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Leidos quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.